Usv Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
One of their notable products is DAPAGLIFLOZIN (DAPAGLIFLOZIN 30% W/W SOLUTION IN ISOPROPYL ALCOHOL), with a corresponding US DMF Number 36903.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 09, 2022, and payment made on March 22, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II